The DOI matches its Crossref record.
Elevated Serum IP-10 Levels Observed in Type 1 Diabetes
Open accessAbstract
OBJECTIVE—Although most patients with type 1 diabetes are considered to have T-cell–mediated autoimmune disease, a method of measuring of pancreatic β-cell–specific T-cell function in cases of type 1 diabetes has yet to be established. Here, we focused on interferon-inducible protein-10 (IP-10), a chemokine that promotes the migration of activated T-helper 1 (Th1) cells and measured serum IP-10 levels in patients with human type 1 diabetes, which is regarded as a Th1-mediated disease. RESEARCH DESIGN AND METHODS—Serum samples were obtained from diabetic patients, and the levels of autoantibodies (GAD and insulinoma-associated protein-2 [IA-2]) and IP-10 were measured. Diabetic patients positive for either or both of the autoantibodies were classified as Ab+ type 1, and those negative for both were classified as Ab− type 1. To evaluate islet antigen–specific responses, peripheral blood from patients stimulated with or without GAD was used, and intracellular cytokine staining for flowcytometry was performed. RESULTS—The Ab+ and Ab− type 1 groups both showed a significantly higher serum IP-10 level than the healthy subjects (P < 0.001 and P < 0.05, respectively), and the IP-10 level in the recent-onset Ab+ subgroup was significantly higher than that in the established (longstanding) Ab+ subgroup (P < 0.002). Furthermore, there was a significant positive correlation between the serum IP-10 level and the number of GAD-reactive γ-interferon–producing CD4+ cells in the Ab+ type 1 group (P < 0.007). CONCLUSIONS—Our findings demonstrate that measurement of serum IP-10 concentrations is useful in patients with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The role of inflammation in insulitis and β-cell loss in type 1 diabetes
Eizirik, D. L., Colli, M. L., & Ortis, F. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.21 · Cited by 1,011
Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases
Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.010 · Cited by 595
High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells
Shanmugam, N., Reddy, M. A., Guha, M., & Natarajan, R. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1256 · Cited by 526
CXCR3 ligands in disease and therapy
Van Raemdonck, K., Van den Steen, P. E., Liekens, S., Van Damme, J., & Struyf, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.009 · Cited by 310
Imagawa, A., Hanafusa, T., Uchigata, Y., Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., Shimizu, I., Toyoda, T., Maruyama, T., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2345 · Cited by 292
Self-citation
Metadata
- Authors
- Shimada, A., Morimoto, J., Kodama, K., Suzuki, R., Oikawa, Y., Funae, O., Kasuga, A., Saruta, T., & Narumi, S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-03-01
- Volume
- 24
- Issue
- 3
- Pages
- 510-515
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1996044268
- Cited by
- 162
- References
- 0
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated Serum IP-10 Levels Observed in Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/diacare.24.3.510
- The paper
- Shimada, A., Morimoto, J., Kodama, K., Suzuki, R., Oikawa, Y., Funae, O., Kasuga, A., Saruta, T., & Narumi, S. (2001). Elevated Serum IP-10 Levels Observed in Type 1 Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.24.3.510
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.